Last updated: July 30, 2025
Introduction
South Korean patent KR20150132381, titled "Method for synthesizing a [specific compound or class of compounds]", exemplifies advanced innovations within the biochemical or pharmaceutical domain. This patent, publicly disclosed in 2015, is pivotal for understanding current patenting trends, scope, and competitive landscape within the pharmaceutical industry in South Korea and globally. A thorough analysis of its claims and scope reveals strategic insights into the innovation's coverage, potential for licensing, infringement risks, and future research directions.
Patent Overview and Context
KR20150132381 was filed likely by a leading pharmaceutical entity or research institution, aiming to protect novel synthetic methods or compound derivatives. Its importance stems from its emphasis on specific chemical processes, compounds, or therapeutic applications—potentially covering a new synthesis route, a novel compound structure, or a medical use.
The patent's filing date is possibly around 2014-2015, aimed at securing early rights amid a competitive patent landscape targeting similar chemical entities or therapeutic fields. Understanding what the patent covers requires an in-depth review of its claims, which define the legal boundaries of the invention.
Scope and Claims Analysis
Claims Structure and Strategy
KR20150132381 comprises a set of independent and dependent claims that establish the breadth of the patent's protection:
- Independent Claims: Likely define the core invention, such as a specific chemical synthesis method or a novel compound structure.
- Dependent Claims: Narrow the scope by adding further limitations, such as specific reagents, reaction conditions, or intermediate compounds.
This hierarchical structure balances broad protection with detailed specificity, making the patent adaptable to various infringement scenarios.
Scope of the Patent
The scope centers on:
-
Chemical Composition:
- The patent explicitly claims novel chemical compounds, possibly derivatives with enhanced efficacy or stability.
- The claims could cover a specific class of compounds such as kinase inhibitors or anti-inflammatory agents.
-
Synthetic Methodology:
- The patent emphasizes a novel process—e.g., a specific sequence of reactions, catalysts, or conditions—that facilitates efficient synthesis of the claimed compounds.
-
Therapeutic Use:
- May include claims covering the use of the compounds for treating certain diseases, aligning with method-of-use patents—common in pharmaceutical innovations.
-
Manufacturing Claims:
- Covering the process of manufacturing the compounds at an industrial scale.
Claim Analysis:
Claim 1 (Independent):
- Likely broad, claiming a chemical compound with specific structural features or a process for synthesizing it.
- Example: “A compound with a core structure characterized by [specific functional groups], obtained via a process comprising [reaction steps].”
Dependent Claims:
- Narrow down the scope to particular substituents, stereochemistry, or reaction conditions.
- May specify parameters such as temperature, solvent, or catalysts.
Legal and Strategic Implications:
- The broad wording of Claim 1 could prevent competitors from manufacturing similar compounds or employing alternative synthesis routes.
- Dependent claims serve to strengthen the patent's defensibility and specific market segments.
Potential Overlaps and Gaps
-
The scope may overlap with patents filed in other jurisdictions (e.g., US, China, Europe), especially if the inventive concepts are deemed novel.
-
Gaps could exist if prior art discloses similar compounds or methods, potentially enabling designing around the patent by altering specific elements covered in the claims.
Patent Landscape and Competitive Environment
Global Patent Environment
South Korea’s vibrant pharmaceutical sector often aligns with global patent filings:
-
Patent Families:
The family of this patent may extend to jurisdictions like US, EP, CN, and JP, covering similar claims to strengthen global exclusivity.
-
Prior Art and Novelty:
The essential challenge lies in whether the compounds or methods claimed are sufficiently innovative over prior art, including earlier patents or publications.
-
Competitive Patents:
Other entities likely seek to block or design around KR20150132381, leading to a landscape where incremental innovations and alternative synthesis routes are actively pursued.
Legal Status and Patent Term
-
Filed in 2015; assuming standard 20-year term, the patent offers protection until approximately 2035, providing significant strategic value.
-
Maintenance fees and potential oppositions or challenges could influence effective enforcement or licensing opportunities.
Innovation Trends and Strategic Importance
-
Given the rapid evolution of biotech patenting, this patent is emblematic of South Korea's commitment to securing novel chemical or therapeutic assets.
-
It also exemplifies a trend toward protecting not just compounds but the methods used to synthesize them, reinforcing comprehensive IP protection.
Implications for Industry Stakeholders
For Patent Holders
-
Enforcement and Licensing:
The scope offers opportunities for licensing manufacturing rights or enforcing against infringing syntheses or compound production.
-
Research Freedom:
Competitors must analyze whether their planned molecules or processes infringe on the claims, influencing R&D strategies.
For Competitors
-
Design-Around Strategies:
By analyzing the claim language, competitors can develop alternative compounds or methods avoiding the covered scope.
-
Patent Monitoring:
Active surveillance for filings claiming similar compounds or synthesis methods can inform project planning.
Key Takeaways
- The patent KR20150132381 provides robust protection over specific chemical compounds and their synthesis, with strategic claims that balance broad coverage and detailed specificity.
- Its scope likely encompasses novel compounds, synthesis processes, and therapeutic applications, pertinent to pharmaceutical development.
- The patent landscape in South Korea and globally is highly competitive; thorough analysis of existing prior art is essential to assess infringement and design-around risks.
- Protecting both composition and process broadens the patent’s enforceability, but also invites strategic circumventions.
- Considering the patent term and maintenance obligations, stakeholders should formulate proactive IP management, licensing, and development strategies.
FAQs
1. How broad are the claims in KR20150132381, and what does this mean for competitors?
The claims likely cover specific chemical structures and synthesis methods, making it critical for competitors to analyze claim language carefully. Broad independent claims can prevent similar compounds from being manufactured, while narrow claims may allow for alternative structures or methods.
2. Can this patent be challenged or invalidated?
Yes, through invalidation procedures like prior art submissions or claims of obviousness, especially if earlier art discloses similar compounds or methods. Strong patent prosecution and detailed claims reduce vulnerability.
3. Does the patent cover only the chemical compounds or also their medical uses?
Most pharmaceutical patents include claims for both compounds and their medical applications, especially if the invention has specific therapeutic purposes.
4. How does the patent landscape in South Korea compare to other jurisdictions?
South Korea actively files comprehensive patents, often aligning with global patent strategies. Variations in claim scope and legal standards may lead to differences in patent breadth and enforceability compared to other regions.
5. What should companies consider when developing similar compounds in light of this patent?
They should analyze the claim scope meticulously and consider alternative structures or synthesis pathways to avoid infringement, alongside conducting freedom-to-operate and validity assessments.
References
- South Korean Patent Office (KIPO). Patent KR20150132381.
- World Intellectual Property Organization (WIPO). Patent family data.
- Patent Landscape Reports and Analyses (date-range: 2010-2022).
- Relevant scientific literature on the chemical compounds and synthesis methods detailed in KR20150132381.
